Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Rhea-AI Summary

Passage Bio (NASDAQ: PASG) announced that Will Chou, M.D., president and CEO, will participate in a fireside chat at the Guggenheim Securities 2nd Annual Healthcare Innovation Conference on Wednesday, November 12, 2025 at 9:30 a.m. ET in Boston.

A live webcast will be available on the company’s Investors & News website at investors.passagebio.com, and a replay will be available for 90 days following the event.

News Market Reaction – PASG

+0.90%

1 alert

+0.90% News Effect

On the day this news was published, PASG gained 0.90%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

PHILADELPHIA, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that Will Chou, M.D., president and chief executive officer, will participate in a fireside chat during the Guggenheim Securities 2^nd Annual Healthcare Innovation Conference on Wednesday, November 12, 2025 at 9:30 a.m. ET in Boston, MA.

A live webcast of the event will be available on the Investors & News section of Passage Bio’s website at investors.passagebio.com. A replay of the event will be available for 90 days following the event.

About Passage Bio

Passage Bio (Nasdaq: PASG) is a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time therapies designed to target the underlying pathology of these conditions. Passage Bio’s lead product candidate, PBFT02, seeks to treat neurodegenerative conditions, including frontotemporal dementia, by elevating progranulin levels to restore lysosomal function and slow disease progression. 

To learn more about Passage Bio and our steadfast commitment to protecting patients and families against loss in neurodegenerative conditions, please visit: passagebio.com.

For further information, please contact:

Investors:
Stuart Henderson
Passage Bio
shenderson@passagebio.com

Passage Bio Media:
Mike Beyer
Sam Brown Inc. Healthcare Communications
312.961.2502
mikebeyer@sambrown.com

FAQ

When will Passage Bio (PASG) present at the Guggenheim Healthcare Innovation Conference?

Will Chou will speak on Wednesday, November 12, 2025 at 9:30 a.m. ET.

How can investors watch the Passage Bio (PASG) fireside chat webcast on November 12, 2025?

The live webcast will be available on Passage Bio's Investors & News page at investors.passagebio.com.

Will there be a replay of the Passage Bio (PASG) presentation from the conference?

Yes. A replay will be available for 90 days after the event on the investor site.

Who from Passage Bio (PASG) will participate in the Guggenheim conference fireside chat?

Will Chou, M.D., president and chief executive officer, will participate in the fireside chat.

Where is the Guggenheim Securities 2nd Annual Healthcare Innovation Conference taking place on November 12, 2025?

The conference will be held in Boston, MA.